FDA approves O-T-C designation for Emergent BioSolutions’ NARCAN Nasal Spray
GAITHERSBURG, Md. — Emergent BioSolutions announced Wednesday that the U.S. Food and Drug Administration (FDA) has approved NARCAN Naloxone HCl Nasal Spray 4 mg as an over-the-counter (O-T-C) emergency treatment of opioid overdose. This decision comes at a time when approximately every eight minutes, a person dies from an opioid overdose and research shows the
